The high degree of antigenic variability, an absence of preventive vaccines for parasitic diseases, and the unavailability of immunological correlates poses as an obstacle to the development of vaccines for tropical infectious diseases such as Malaria. In the upcoming World Vaccine Congress Asia 2013, Mr. Toshihiro Horii will be speaking on the topic “Malaria: Innovating prophylactic vaccine pipeline for tropical infectious diseases”. Apart from reviewing the epidemiology of malaria-epidemic regions in Asia and Africa and the potential for Malaria vaccine development in Asia, he will also be presenting the clinical development of BK-SE36 Phase 1b in Uganda: a blood-stage vaccine for Plasmodium falciparum malaria. In addition, Mr. Horii will share on how to implement strategies to overcome the challenges of transition to phase II trials.
Mr. Toshihiro Horii is currently the Director of the Research Centre for Infectious Disease Control and International Research Centre for Infectious Diseases in the Research Institute for Microbial Diseases, Osaka University, Japan. He previously held positions such as the Associate Professor in the Department of Molecular Protozoology and the Research Assistant Professor in the Department of Microbiology.